Decreasing Inappropriate Use of Rasburicase to Promote Cost-Effective Care. [electronic resource]
- Journal of oncology practice 02 2019
- e178-e186 p. digital
Publication Type: Journal Article
1935-469X
10.1200/JOP.18.00528 doi
Cost-Benefit Analysis Delivery of Health Care Disease Management Health Care Costs Humans Practice Patterns, Physicians' Prescription Drug Overuse Quality Assurance, Health Care Quality Improvement Tumor Lysis Syndrome--drug therapy Urate Oxidase--therapeutic use